Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CS/HIPEC) in colorectal cancer: evidence-based review of patient selection and treatment algorithms

Abstract Cytoreduction and heated intraperitoneal chemotherapy (CS/HIPEC) is increasingly utilized as a treatment strategy for patients with peritoneal metastases from various primary tumor sites. For this heterogenous procedure, related to patient characteristics, patient selection, and the extent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of surgical oncology 2017-06, Vol.43 (6), p.1028-1039
Hauptverfasser: Maciver, Allison, MD, Lee, Nara, MD, Skitzki, Joseph J., MD, FACS, Boland, Patrick, MD, Francescutti, Valerie, MD, MSc, FRCSC, FACS
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1039
container_issue 6
container_start_page 1028
container_title European journal of surgical oncology
container_volume 43
creator Maciver, Allison, MD
Lee, Nara, MD
Skitzki, Joseph J., MD, FACS
Boland, Patrick, MD
Francescutti, Valerie, MD, MSc, FRCSC, FACS
description Abstract Cytoreduction and heated intraperitoneal chemotherapy (CS/HIPEC) is increasingly utilized as a treatment strategy for patients with peritoneal metastases from various primary tumor sites. For this heterogenous procedure, related to patient characteristics, patient selection, and the extent of surgical completeness of cytoreduction, high level evidence (ex: multiple randomized controlled trials) is not available to support efficacy. This review of the available literature supporting application of the procedure, focusing on colorectal cancer, provides a summary of current evidence for patient selection and treatment algorithms based on patient presentation.
doi_str_mv 10.1016/j.ejso.2016.09.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1853741068</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0748798316309015</els_id><sourcerecordid>1853741068</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-bd2698c9238011054a1080c6b002ada58d9c6e5953720890cbc16cde4a1a95a43</originalsourceid><addsrcrecordid>eNp9Uk2L1TAULaI4z9E_4EKyHBft3KSfERGkjL4HAwqj65Am9_lS26YmqdJ_40815Y0KLlzl3uScc8k5N0meU8go0Oq6z7D3NmOxzoBnQNmDZEfLnKWMlvXDZAd10aQ1b_KL5In3PQDwvOaPkwvWAOMly3fJz3YN1qFeVDB2InLSZL_O6MIJ3WgUOUzBydibYCeUA2lPONrtUc4ruWrvrveHjzftS2ImouwQlVSIKCUnhe4Vwe9GYyzTTnrUxMUefxB7JLMMBqdAPA74d3JwKMO43cvhi40zT6N_mjw6ysHjs_vzMvn87uZTu09vP7w_tG9vU1VQGtJOs4o3irO8AUqhLCSFBlTVATCpZdlorioseZnXDBoOqlO0UhojTvJSFvllcnXWnZ39tqAPYjRe4TDICe3iBW0itaBQNRHKzlDlrPcOj2J2ZpRuFRTElozoxZaM2JIRwEVMJpJe3Osv3Yj6D-V3FBHw-gzA-MvokxNemc08bTZXhbbm__pv_qGrwUxGyeErruh7u7gp-ieo8EyAuNt2Y1sNWuXAIW7NL35ntto</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1853741068</pqid></control><display><type>article</type><title>Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CS/HIPEC) in colorectal cancer: evidence-based review of patient selection and treatment algorithms</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Maciver, Allison, MD ; Lee, Nara, MD ; Skitzki, Joseph J., MD, FACS ; Boland, Patrick, MD ; Francescutti, Valerie, MD, MSc, FRCSC, FACS</creator><creatorcontrib>Maciver, Allison, MD ; Lee, Nara, MD ; Skitzki, Joseph J., MD, FACS ; Boland, Patrick, MD ; Francescutti, Valerie, MD, MSc, FRCSC, FACS</creatorcontrib><description>Abstract Cytoreduction and heated intraperitoneal chemotherapy (CS/HIPEC) is increasingly utilized as a treatment strategy for patients with peritoneal metastases from various primary tumor sites. For this heterogenous procedure, related to patient characteristics, patient selection, and the extent of surgical completeness of cytoreduction, high level evidence (ex: multiple randomized controlled trials) is not available to support efficacy. This review of the available literature supporting application of the procedure, focusing on colorectal cancer, provides a summary of current evidence for patient selection and treatment algorithms based on patient presentation.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1016/j.ejso.2016.09.012</identifier><identifier>PMID: 28029523</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adenocarcinoma - secondary ; Adenocarcinoma - therapy ; Algorithms ; Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage ; Carcinomatosis ; Chemoperfusion ; Colorectal cancer ; Colorectal Neoplasms - pathology ; Colorectal Neoplasms - therapy ; Cytoreduction ; Cytoreduction Surgical Procedures - methods ; Evidence-Based Medicine ; Hematology, Oncology and Palliative Medicine ; HIPEC ; Humans ; Hyperthermia, Induced - methods ; Infusions, Parenteral ; Patient Selection ; Peritoneal Neoplasms - secondary ; Peritoneal Neoplasms - therapy ; Surgery</subject><ispartof>European journal of surgical oncology, 2017-06, Vol.43 (6), p.1028-1039</ispartof><rights>Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology</rights><rights>2016 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology</rights><rights>Copyright © 2016 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-bd2698c9238011054a1080c6b002ada58d9c6e5953720890cbc16cde4a1a95a43</citedby><cites>FETCH-LOGICAL-c411t-bd2698c9238011054a1080c6b002ada58d9c6e5953720890cbc16cde4a1a95a43</cites><orcidid>0000-0003-3393-9279</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejso.2016.09.012$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28029523$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maciver, Allison, MD</creatorcontrib><creatorcontrib>Lee, Nara, MD</creatorcontrib><creatorcontrib>Skitzki, Joseph J., MD, FACS</creatorcontrib><creatorcontrib>Boland, Patrick, MD</creatorcontrib><creatorcontrib>Francescutti, Valerie, MD, MSc, FRCSC, FACS</creatorcontrib><title>Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CS/HIPEC) in colorectal cancer: evidence-based review of patient selection and treatment algorithms</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Abstract Cytoreduction and heated intraperitoneal chemotherapy (CS/HIPEC) is increasingly utilized as a treatment strategy for patients with peritoneal metastases from various primary tumor sites. For this heterogenous procedure, related to patient characteristics, patient selection, and the extent of surgical completeness of cytoreduction, high level evidence (ex: multiple randomized controlled trials) is not available to support efficacy. This review of the available literature supporting application of the procedure, focusing on colorectal cancer, provides a summary of current evidence for patient selection and treatment algorithms based on patient presentation.</description><subject>Adenocarcinoma - secondary</subject><subject>Adenocarcinoma - therapy</subject><subject>Algorithms</subject><subject>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</subject><subject>Carcinomatosis</subject><subject>Chemoperfusion</subject><subject>Colorectal cancer</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Colorectal Neoplasms - therapy</subject><subject>Cytoreduction</subject><subject>Cytoreduction Surgical Procedures - methods</subject><subject>Evidence-Based Medicine</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>HIPEC</subject><subject>Humans</subject><subject>Hyperthermia, Induced - methods</subject><subject>Infusions, Parenteral</subject><subject>Patient Selection</subject><subject>Peritoneal Neoplasms - secondary</subject><subject>Peritoneal Neoplasms - therapy</subject><subject>Surgery</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uk2L1TAULaI4z9E_4EKyHBft3KSfERGkjL4HAwqj65Am9_lS26YmqdJ_40815Y0KLlzl3uScc8k5N0meU8go0Oq6z7D3NmOxzoBnQNmDZEfLnKWMlvXDZAd10aQ1b_KL5In3PQDwvOaPkwvWAOMly3fJz3YN1qFeVDB2InLSZL_O6MIJ3WgUOUzBydibYCeUA2lPONrtUc4ruWrvrveHjzftS2ImouwQlVSIKCUnhe4Vwe9GYyzTTnrUxMUefxB7JLMMBqdAPA74d3JwKMO43cvhi40zT6N_mjw6ysHjs_vzMvn87uZTu09vP7w_tG9vU1VQGtJOs4o3irO8AUqhLCSFBlTVATCpZdlorioseZnXDBoOqlO0UhojTvJSFvllcnXWnZ39tqAPYjRe4TDICe3iBW0itaBQNRHKzlDlrPcOj2J2ZpRuFRTElozoxZaM2JIRwEVMJpJe3Osv3Yj6D-V3FBHw-gzA-MvokxNemc08bTZXhbbm__pv_qGrwUxGyeErruh7u7gp-ieo8EyAuNt2Y1sNWuXAIW7NL35ntto</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Maciver, Allison, MD</creator><creator>Lee, Nara, MD</creator><creator>Skitzki, Joseph J., MD, FACS</creator><creator>Boland, Patrick, MD</creator><creator>Francescutti, Valerie, MD, MSc, FRCSC, FACS</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3393-9279</orcidid></search><sort><creationdate>20170601</creationdate><title>Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CS/HIPEC) in colorectal cancer: evidence-based review of patient selection and treatment algorithms</title><author>Maciver, Allison, MD ; Lee, Nara, MD ; Skitzki, Joseph J., MD, FACS ; Boland, Patrick, MD ; Francescutti, Valerie, MD, MSc, FRCSC, FACS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-bd2698c9238011054a1080c6b002ada58d9c6e5953720890cbc16cde4a1a95a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenocarcinoma - secondary</topic><topic>Adenocarcinoma - therapy</topic><topic>Algorithms</topic><topic>Antineoplastic Combined Chemotherapy Protocols - administration &amp; dosage</topic><topic>Carcinomatosis</topic><topic>Chemoperfusion</topic><topic>Colorectal cancer</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Colorectal Neoplasms - therapy</topic><topic>Cytoreduction</topic><topic>Cytoreduction Surgical Procedures - methods</topic><topic>Evidence-Based Medicine</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>HIPEC</topic><topic>Humans</topic><topic>Hyperthermia, Induced - methods</topic><topic>Infusions, Parenteral</topic><topic>Patient Selection</topic><topic>Peritoneal Neoplasms - secondary</topic><topic>Peritoneal Neoplasms - therapy</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maciver, Allison, MD</creatorcontrib><creatorcontrib>Lee, Nara, MD</creatorcontrib><creatorcontrib>Skitzki, Joseph J., MD, FACS</creatorcontrib><creatorcontrib>Boland, Patrick, MD</creatorcontrib><creatorcontrib>Francescutti, Valerie, MD, MSc, FRCSC, FACS</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maciver, Allison, MD</au><au>Lee, Nara, MD</au><au>Skitzki, Joseph J., MD, FACS</au><au>Boland, Patrick, MD</au><au>Francescutti, Valerie, MD, MSc, FRCSC, FACS</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CS/HIPEC) in colorectal cancer: evidence-based review of patient selection and treatment algorithms</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>43</volume><issue>6</issue><spage>1028</spage><epage>1039</epage><pages>1028-1039</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Abstract Cytoreduction and heated intraperitoneal chemotherapy (CS/HIPEC) is increasingly utilized as a treatment strategy for patients with peritoneal metastases from various primary tumor sites. For this heterogenous procedure, related to patient characteristics, patient selection, and the extent of surgical completeness of cytoreduction, high level evidence (ex: multiple randomized controlled trials) is not available to support efficacy. This review of the available literature supporting application of the procedure, focusing on colorectal cancer, provides a summary of current evidence for patient selection and treatment algorithms based on patient presentation.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28029523</pmid><doi>10.1016/j.ejso.2016.09.012</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-3393-9279</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0748-7983
ispartof European journal of surgical oncology, 2017-06, Vol.43 (6), p.1028-1039
issn 0748-7983
1532-2157
language eng
recordid cdi_proquest_miscellaneous_1853741068
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adenocarcinoma - secondary
Adenocarcinoma - therapy
Algorithms
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Carcinomatosis
Chemoperfusion
Colorectal cancer
Colorectal Neoplasms - pathology
Colorectal Neoplasms - therapy
Cytoreduction
Cytoreduction Surgical Procedures - methods
Evidence-Based Medicine
Hematology, Oncology and Palliative Medicine
HIPEC
Humans
Hyperthermia, Induced - methods
Infusions, Parenteral
Patient Selection
Peritoneal Neoplasms - secondary
Peritoneal Neoplasms - therapy
Surgery
title Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CS/HIPEC) in colorectal cancer: evidence-based review of patient selection and treatment algorithms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T03%3A21%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytoreduction%20and%20Hyperthermic%20Intraperitoneal%20Chemotherapy%20(CS/HIPEC)%20in%20colorectal%20cancer:%20evidence-based%20review%20of%20patient%20selection%20and%20treatment%20algorithms&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Maciver,%20Allison,%20MD&rft.date=2017-06-01&rft.volume=43&rft.issue=6&rft.spage=1028&rft.epage=1039&rft.pages=1028-1039&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1016/j.ejso.2016.09.012&rft_dat=%3Cproquest_cross%3E1853741068%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1853741068&rft_id=info:pmid/28029523&rft_els_id=1_s2_0_S0748798316309015&rfr_iscdi=true